Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia.

Chiara Di Pede,Sabrina Congedi,Sara Rossin,Antuan Divisic, Alesandra De Gregorio,Caterina Agosto, Igor Catalano,Alessandro Mazza,Leonardo Sartori,Stefano Masiero,Franca Benini

CASE REPORTS IN PEDIATRICS（2016）

引用 9|浏览9

暂无评分

摘要

We describe a case of a paediatric patient affected by mandibular fibrous dysplasia (FD) with severe and chronic pain who was successfully treated with zoledronic acid (ZOL): a third-generation bisphosphonate. Further research is needed to assess its safety and efficacy as a treatment option for FD in the paediatric population.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要